For the Inventor, By the Inventor

Enter assignee name

Budapest, Hungary

Richter Gedeon Nyrt.

USPTO Granted Patents = 63

% Expired Patents = 25.4

CIPO Patents = 13

EPO Patents = 82

Forward Citations = 126

Loading Chart...

Loading Chart...

182 inventors (with patents filed for the assignee):

Sándor Mahó (8 out of 16 patents)

János Csörgei (7 out of 9 patents)

Csaba Sánta (7 out of 9 patents)

4. Eva Againe Csongor (7 out of 11 patents)

5. János Éles (6 out of 11 patents)

6. Gábor Balogh (6 out of 14 patents)

7. Anil Chhettry (6 out of 8 patents)

8. Georg Schramm (6 out of 8 patents)

9. Mahendra G Dedhiya (6 out of 24 patents)

10. Ranajoy Sarkar (6 out of 6 patents)

11. Laszlo Czibula (5 out of 21 patents)

12. Zoltán Béni (4 out of 4 patents)

13. István Borza (4 out of 5 patents)

14. Viktor Román (4 out of 4 patents)

15. Istvan Gyertyan (4 out of 24 patents)

Core Competencies:

Pharmaceutical Formulations

Immunoglobulin Purification

Dopamine Receptor Ligands

GABAA Modulators

Heterocyclic Derivatives

Piperazine Compounds

Hormonal Contraceptives

Optical Isomers

G-CSF Refolding

Antibody Formulations

Thiadiazine Derivatives

63 patents: Sort by Forward Citations

1. 12735430 - Crystalline solvated forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea (2026-09-15),

2. 12649738 - 1,3-dihydro-2H-pyrrolo[3,4-c]pyridine derivatives as GABAα5 receptor modulators (2026-06-09),

3. 12637455 - Naphthyridine and pyrido[3,4-c]pyridazine derivatives as GABAα5 receptor modulators (2026-05-26),

4. 12600748 - Affinity chromatography of immunoglobulins by using pre-capture flocculation (2026-04-14),

5. 12540160 - METHODS FOR THE PURIFICATION OF REFOLDED FC-PEPTIDE FUSION PROTEIN (2026-02-03),

6. 12473293 - Pharmacologically active heterocyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives (2025-11-18),

7. 12433948 - Aqueous pharmaceutical formulations (2025-10-07),

8. 12370182 - Bicyclic derivatives as GABAA A5 receptor modulators (2025-07-29),

9. 12194050 - Thiadiazine derivatives (2025-01-14),

10. 12168791 - Method for modifying the glycosylation profile of a recombinant glycoprotein produced in cell culture (2024-12-17),

11. 12168007 - Substituted piperazines as dopamine D3/D2 receptor modulators (2024-12-17),

12. 11633406 - Industrial process for the preparation of high purity estetrol (2023-04-25),

13. 11547707 - Carbamoyl cyclohexane derivatives for treating autism spectrum disorder (2023-01-10),

14. RE49302 - Pharmaceutical formulations containing dopamine receptor ligands (2022-11-14),

15. 11427639 - Antibody-containing aqueous formulation and use thereof (2022-08-30),

Company Overview

Richter Gedeon Nyrt. is a prominent Hungarian pharmaceutical company headquartered in Budapest, specializing in the development and manufacturing of innovative pharmaceutical formulations. The company focuses on a diverse range of therapeutic areas, including hormonal contraceptives and central nervous system disorders, leveraging advanced technologies such as immunoglobulin purification and the development of dopamine receptor ligands. Richter is committed to enhancing healthcare through its expertise in heterocyclic derivatives and piperazine compounds, contributing significantly to the global pharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

63 Patents

#3 in Budapest

#3 in Hungary

#11,640 in the World

Budapest, Hungary

Richter Gedeon Nyrt.

Forward Citations = 126

182 inventors:

Sándor Mahó (8 out of 16 patents)

János Csörgei (7 out of 9 patents)

Csaba Sánta (7 out of 9 patents)

4. Eva Againe Csongor (7 out of 11 patents)

5. János Éles (6 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Richter Gedeon Nyrt.. Retrieved from https://idiyas.com/company/richter-gedeon-nyrt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…